A Study of NINLARO® in Chinese Adults With Multiple Myeloma

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

October 29, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Multiple Myeloma
Interventions
OTHER

No intervention

This is a non-interventional study.

Trial Locations (12)

100020

RECRUITING

Beijing Chao-Yang Hospital,Capital Medical University, Beijing

100096

RECRUITING

Beijing Jishuitan Hospital, Beijing

110022

RECRUITING

Shengjing Hospital affiliated to China Medical University, Shenyang

215006

RECRUITING

The First Affiliated Hospital of Soochow University, Suzhou

230000

RECRUITING

Anhui Cancer Hospital, Hefei

266071

RECRUITING

Qingdao Municipal Hospital, Qingdao

300052

RECRUITING

Tianjin Medical University General Hospital, Tianjin

330006

RECRUITING

The First Affiliated Hospital of Nanchang University, Nanchang

450004

RECRUITING

Henan Province People Hospital, Zhengzhou

450052

RECRUITING

The First Affiliated Hospital of Zhenzhou University, Zhengzhou

610000

RECRUITING

West China Hospital, Sichuan University, Chengdu

010050

RECRUITING

Affiliated Hospital of Inner Mongolia Medical University, Hohhot

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY